DAFLON 500 mg, film-coated tablet 30 tablets
Brand page: Daflon (diosmin + hesperidin (micronised purified flavonoid fraction)) — all forms and strengths in France
Active ingredients: Diosmin, FRACTION FLAVONOÏQUE PURIFIÉE MICRONISÉE, Hesperidin
Commercialized according to BDPM
Film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DAFLON 500 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 30 comprimé(s)
- Marketing authorisation holder
- LES LABORATOIRES SERVIER
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 19 May 1987
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60491130CIP73286600CIP133400932866007Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DIOSMINEcomprimé | 450 mg · un comprimé | FT |
| HESPÉRIDINEcomprimé | 50 mg · un comprimé | FT |
| FRACTION FLAVONOÏQUE PURIFIÉE MICRONISÉEcomprimé | 500 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.